(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT

ST13

US500000079362259

Classe

39, 40, 42, 44

Pedido

79362259

Registro

7334071

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

30

Atualização mais recente

19/12/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

39, 40, 42, 44

Data de depósito

23/05/2022

Data de registro

26/03/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

26/03/2024

Última transação

19/12/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

99

Localização do titular

DE

Examinador

OAKES,JEFFREY ALLEN

Unidade examinadora

O10

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the stacked wording "XPERT ALLIANCE" in blue. To the right of the term "XPERT" appears the wording "RENTSCHLER" in orange above the wording "& VETTER" in orange. All the aforesaid appears above the wording "SUBSTANCE PRODUCT PATIENT" in black with these terms separated by orange triangles.

Titulares e representantes

Titulares

R. S. (pessoa física)
Vetter Pharma-Fertigung GmbH & Co. KG

Representantes

Walter Hill Levie III MEUNIER CARLIN & CURFMAN LLC

Classificação técnica

Classes Nice

Classe 39Classe 40Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 39

Bottling services and storage of goods in the nature of liquid and solid substancesespeciallypharmaceuticalsmedicines and solutionsfor others

Classe 40

Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for otherscustom manufacture and assembly servicescustom assembly for others of electronic components for medical devices and apparatussemiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic componentssemi-conductor components and circuits for medical apparatus and equipment

Classe 42

Scientific and technological servicesscientific researchanalysistesting and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research serviceschemicalbiochemicalbiological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry serviceschemistry consultationresearch in the fields of chemistry; biochemical servicesbiochemistry consultationresearch in the fields of biochemistry; services of medicalbacteriological and chemical laboratorieslaboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceuticalveterinary and diagnostic products and substances and methods for the manufacture thereofin particular using biotechnological and genetically-engineered meansin the nature of research in the field of manufacturing machinery for pharmaceuticalveterinary and diagnostic products and substancesdesign and development of computer hardware for the pharmaceuticalveterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacyconsulting services in the field of pharmaceutical research and developmenttechnical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnosticsconsulting services in the field of pharmaceutical research and developmentconsulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injectionsinjectors and packaging for the aforesaid goods for others; product quality and product safety testingchemical testingphysical testing and process engineering testingin particular laboratory testing; pharmacological and microbiological developmentresearch and analysis for others; conducting clinical testsscientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy

Classe 44

Medical services; medical assistance; animal healthcare servicesanimal breedinganimal groomingmedical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical productsproviding medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products

Publicações

Histórico de despachos e eventos da marca no USPTO.

30 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

18/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

23/11/2024

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

08/10/2024

XXCR

GENERIC MADRID TRANSACTION CREATED

08/10/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

27/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

26/03/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

26/03/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/01/2024

PUBO

PUBLISHED FOR OPPOSITION

09/01/2024

GPNX

NOTIFICATION PROCESSED BY IB

08/01/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

20/12/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

20/12/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

20/12/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/12/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

05/12/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/12/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

05/12/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/12/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/11/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/11/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/11/2023

RFNP

REFUSAL PROCESSED BY IB

07/06/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/05/2023

RFRR

REFUSAL PROCESSED BY MPU

11/05/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

22/03/2023

CNRT

NON-FINAL ACTION WRITTEN

21/03/2023

DOCK

ASSIGNED TO EXAMINER

11/03/2023

MAFR

APPLICATION FILING RECEIPT MAILED

14/02/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/02/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/02/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.